Palvella Puts U.S. DSAP Population at 154,986 in New Posters
Palvella Therapeutics posters estimate 154,986 U.S. patients with disseminated superficial actinic porokeratosis, sharpening the epidemiological picture for the rare skin disease.
Topic
Rare Skin Disease
Topic
Rare Skin Disease
Generalized Pustular Psoriasis Prevalence Rises 56% Over 15 Years
GPP prevalence climbed 56% over 15 years, Medscape reports, signaling a shift for a rare neutrophilic dermatosis long considered…